JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, H. -Y T.
Right arrow Articles by Neff, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, H. -Y T.
Right arrow Articles by Neff, N. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 187, Issue 2, 365-371, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


beta-PHENYLETHYLAMINE: A SPECIFIC SUBSTRATE FOR TYPE B MONOAMINE OXIDASE OF BRAIN

H. -Y T. Yang 1 and N. H. Neff 1

1 Laboratory of Preclinical Pharmacology, National Institute of Mental Health, St. Elizabeth's Hospital, Washington, D.C.

beta-Phenylethylamine and serotonin were oxidatively deaminated by separate forms of monoamine oxidase of rat brain wimen studied in vitro. These forms, designated as type A and type B enzyme, have different characteristics. For example, type A enzyme deaminated serotonin, was sensitive to the drug clorgyline, was resistant to the drug deprenyl and was heat-stable. In contrast, type B enzyme deaminated beta-phenylethylamine, was resistant to clorgyline, was sensitive to deprenyl and was heat-labile. Moreover, type A and type B enzyme activities could be partially separated by centrifugation on a continuous sucrose gradient. beta-Phenylethylamine and serotonin are present in mammalian brain. We conclude from our studies that the amines of brain may be cataboblized by specific types of monoamine oxidase in vivo.

Submitted on March 21, 1973
Accepted on July 13, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.